Skip to main content

Month: February 2021

Red White & Bloom Completes USD $6.12 million Non-Convertible Debenture Financing

TORONTO, Feb. 04, 2021 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB) (OTC: RWBYF) (“RWB” or the “Company”) announces that it closed a debenture unit financing to an arm’s-length investor on a private placement basis.The Debenture is not convertible, unsecured and bears interest at the rate of 7% per annum. The principal amount of the Debenture and accrued interest is payable on April 1, 2022 (the “Maturity Date”).The Company intends to utilize the proceeds from the Private Placement for the following:1) The expansion of its Platinum Vape business as it prepares for its launch in Arizona;2) Funding certain pre-closing operational plans for its previously announced acquisition of a THC Cultivation Center License and Associated Assets in Illinois;3) General corporate and working capital.The Debenture Unit consists...

Continue reading

PENNEXX has Engaged Top Tier PCAOB Audit Firm Assurance Dimensions to Audit Their Financials and Assist the Company in its Up-Listing to OTCQB

Philadelphia, PA, Feb. 04, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Pennexx Foods Inc. (PNNX) signed an agreement with Assurance Dimensions, a certified PCAOB, to begin the formal audit process for the financials necessary to up by utilizing to the OTCQB.Having audited financials provides the public with assurance that their financial statements can be relied upon. This provides an excellent indicator toward investor confidence. Being audited and up-listed to the OTCQB enables the company to be purchased by a greater range of institutional investors.This will validate that Pennexx is maintaining its finances by utilizing generally accepted accounting practices (GAAP), providing transparency.Assurance Dimensions https://assurancedimensions.com was founded in 2008, has four offices in Florida, and services over 400 clients a...

Continue reading

Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2020 Financial Results and Corporate Update

NOVATO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced that it will host a conference call on Thursday, February 11, 2021 at 5pm ET to discuss its financial results and corporate update for the fourth quarter and the year ended December 31, 2020.The live and replayed webcast of the call will be available through the company’s website at https://ir.ultragenyx.com/events-presentations. To participate in the live call by phone, dial (855) 797-6910 (USA) or (262) 912-6260 (International) and enter the passcode 6391931. The replay of the call will be available for one year.About Ultragenyx Pharmaceutical Inc.Ultragenyx is a biopharmaceutical company committed...

Continue reading

CBMJ Featured on Under the Radar Minute on Bloomberg as Emerging into the Spotlight Because of Recent Censorship of Certain Media Segments

Atlanta, GA, Feb. 04, 2021 (GLOBE NEWSWIRE) —via NewMediaWire — Conservative Broadcast Media & Journalism (OTC:CBMJ) www.cbmjinc.com is currently being featured on “The Under The Radar Minute” (UTR) on Bloomberg and other financial new networks of SiriusXM. The Under The Radar Minute is a nationally aired radio segment providing information and awareness of publicly traded companies currently “Under The Radar”. In the segment UTR states that “with an increasing demand for uncensored news and candid commentary, CBMJ’s portals are poised to capture this flood of consumers and the advertisers targeting those consumers.” To read more about CBMJ and to hear the segment visit http://undertheradarminute.com/cbmj.htm In fact, in the past few weeks since censorship and big businesses interference...

Continue reading

WeedMD’s Saturday Cannabis Vaporizers Debut as the Top Seller in Ontario and Color Cannabis Brand Launches 15 gram Dried Flower Products

TORONTO, Feb. 04, 2021 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis is pleased to announce its terpene-infused, one-gram Saturday Cannabis (“Saturday”) vaporizer (“vapes”) was recently named “Top Selling Vape” for the month of January, 2021 at the Ontario Cannabis Store (“OCS”), Canada’s largest cannabis retail distributor. When compared to over 30 available brands, according to OCS-provided data, Saturday ranked first in the one-gram category and when compared to all other vapes sizes, it ranked in the “OCS Top 4”.The Company also confirmed its Color Cannabis products are now available in 15 gram nitrogen-infused pouches through the OCS, in award-winning strains such as Pedro’s Sweet Sativa, Ghost Train Haze,...

Continue reading

Osisko Gold Royalties Provides Notice of Fourth Quarter and Full Year 2020 Results and Conference Call Details

MONTREAL, Feb. 04, 2021 (GLOBE NEWSWIRE) — Osisko Gold Royalties Ltd (“Osisko” or the “Corporation”) (OR: TSX & NYSE) announces that its fourth quarter and full year 2020 results will be released after market on Wednesday, February 24, 2021 followed by a conference call on Thursday, February 25, 2021 at 10:00 am EST.Q4 and Full Year 2020 Results Conference Call InformationThose interested in participating in the conference call should dial in at 1-833-979-2852 (North American Toll Free), or +1-236-714-2915 (International). An operator will direct participants to the call.The conference call replay will be available from 1:00 pm EST on February 25, 2021 until 11:59 pm EST on March 4, 2021 with the following dial in numbers: 1-800-585-8367 (North American Toll Free) or 1-416-621-4642, access code 9484419. The replay will also...

Continue reading

Redevances Aurifères Osisko annonce la date de divulgation de ses résultats financiers pour le quatrième trimestre et l’année 2020, et les détails de la conférence téléphonique

MONTRÉAL, 04 févr. 2021 (GLOBE NEWSWIRE) — Redevances Aurifères Osisko Ltée (« Osisko » ou la « Société ») (TSX et NYSE : OR) annonce qu’elle publiera ses résultats financiers pour le quatrième trimestre et l’année 2020 après la fermeture des marchés, mercredi le 24 février 2021. Une conférence téléphonique aura lieu le lendemain, le 25 février 2021, à 10h00 HNE.Conférence téléphonique portant sur les résultats du quatrième trimestre et de l’année 2020Les personnes intéressées à participer à la conférence téléphonique sont priées de composer le 1 833 979-2852 (sans frais en Amérique du Nord), ou le 1 236 714-2915 (appels internationaux). Un téléphoniste redirigera les participants à la conférence téléphonique.Il sera possible d’écouter l’enregistrement de la conférence à partir du 25 février 2021 à 13h00 HNE jusqu’à 23h59 HNE le...

Continue reading

Gréta María ráðin til Brims sem framkvæmdastjóri Nýsköpunar, samfélagsábyrgðar og fjárfestatengsla

Brim hefur ráðið Grétu Maríu Grétarsdóttur sem framkvæmdastjóra Nýsköpunar, samfélagsábyrgðar og fjárfestatengsla.Brim er leiðandi sjávarútvegsfyrirtæki og tekur virkan þátt í uppbyggingu íslensks samfélags. Hjá Brimi starfa um 800 manns við hin ýmsu störf í virðiskeðju sjávarútvegs. Brim framleiðir afurðir úr sjávarfangi og lögð er rík áhersla á nýsköpun og háþróaða tækni við veiðar og vinnslu sjávarafurða.„Það er ánægjulegt að fá Grétu Maríu til liðs við okkur. Reynsla hennar og áherslur munu hjálpa okkur að efla starfsemi okkar og festa Brim í sessi sem leiðandi sjávarútvegsfyrirtæki“ er haft eftir Guðmundi Kristjánssyni forstjóra Brim.„Ég er mjög ánægð að vera komin til Brims og hlakka til að taka þátt í áframhaldandi uppbyggingu á einu af öflugasta sjávarútvegsfyrirtæki landsins. Brim hefur verið leiðandi í umhverfismálum og við...

Continue reading

Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update

RP1: Initial data in new indications expected in 2021 in anti-PD1 failed NSCLC, anti-PD1 failed CSCC and CSCC solid organ transplant recipient patients; further updates expected to be provided across all studiesRP2: Initial data to be reported in 2021 in combination with Opdivo in Phase 1 all comers studyRP3: First patient dosed; initial single agent data expected to be reported in 2021Commercial-scale facility operational; GMP manufacturing underwayWOBURN, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) — Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today announced financial results for the fiscal third quarter ended December 31, 2020 and provided a business update.“It has been a productive start to 2021,” said Philip Astley-Sparke, Chief Executive...

Continue reading

Zscaler to Host Second Quarter Fiscal Year 2021 Earnings Conference Call

Earnings Results to be released on Thursday, February 25, After the Close of the MarketSAN JOSE, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, will release second quarter fiscal year 2021 earnings after the market closes on Thursday, February 25. The company will host an investor conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss the results.Please dial in at least 10 minutes prior to the 1:30 p.m. PT start time. A live webcast of the conference call will be accessible from the Zscaler website at ir.zscaler.com. Listeners may log on to the call under the “Events & Presentations” section and select “Q2 2021 Zscaler Earnings Conference Call” to participate.A telephone replay of the conference call will be available at approximately 4:30 p.m....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.